Skip to main content
QXL Diagnostics
P1 Molecular ScreeningInvestigation & AssayNABL Accredited Lab (MC-6849)

High-Risk HPV DNA PCR Testing & Genotyping in Bangalore

Advanced molecular screening for Human Papillomavirus. Identifying oncogenic high-risk genotypes 16 and 18 for cervical cancer prevention and wart management.

Clinical Overview

Evidence-Based Understanding & Diagnostic Protocol

Human Papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Over 100 strains exist, broadly categorized into High-Risk (oncogenic) and Low-Risk (non-oncogenic) types.

High-risk HPV types (predominantly 16 and 18, along with 31, 33, 45, 52, 58) are the primary cause of cervical cancer, anal cancer, and oropharyngeal cancers. These high-risk strains do NOT cause visible genital warts; they cause silent cellular dysplasia.

Conversely, low-risk HPV types 6 and 11 cause benign genital warts (condylomata acuminata) and do not lead to cancer. High-Risk HPV DNA PCR detects oncogenic strains years before cellular abnormalities appear on a Pap smear.

Key Clinical Takeaways

  • High-risk HPV causes silent cellular changes; low-risk HPV causes visible benign genital warts.
  • HPV DNA PCR is more sensitive and reliable than a traditional Pap smear alone.
  • Most healthy immune systems naturally clear HPV infections within 12 to 24 months.
  • Co-testing (HPV DNA + Liquid-Based Cytology) is the gold standard cervical screening protocol.
Recommended Investigations

Available Laboratory Assays & Pricing

NABL-accredited diagnostic investigations performed under strict ISO 15189:2022 standards.

Investigation / AssaySpecimen TypeWindow / TimingTurnaround TimePrice (₹)
High-Risk HPV DNA PCR (14/16 Genotypes)
Specifically identifies HPV 16 and 18, with pooled high-risk group detection.
Cervical Swab / Vaginal Swab / Anatomical SwabRoutine / Annual Screening48–72 Hours₹2,800
Liquid-Based Cytology (Pap Smear) + HPV Co-Test
Evaluates cellular morphology alongside oncogenic HPV viral DNA.
Cervical Sample in ThinPrep/SurePathRoutine Screening3–5 Days₹3,400
Strict Confidentiality & Laboratory Governance

Physical Central Facilities in Bengaluru

Samples are processed directly at our NABL-accredited reference laboratory facilities in Kengeri and Yelahanka, operating under ISO 15189:2022 standards (Certificate No. MC-6849). No third-party outsourcing.

Kengeri Hub: 540, 1st Floor, 5th Cross, Kengeri Satellite Town, Bengaluru 560060
Yelahanka Facility: North Bengaluru Referral Centre, Yelahanka, Bengaluru 560064

100% Discrete Patient Privacy Guarantee

  • Numeric Barcoding: Laboratory samples are processed via alphanumeric barcodes without patient names on testing tubes.
  • Encrypted Digital PDF: Password-protected lab reports delivered exclusively to your private WhatsApp or email.
  • Discreet Phlebotomy: Trained phlebotomy specialists available in plain clothes with temperature-controlled cold chain.
Frequently Asked Questions

Direct Questions & Clinical Answers

Clear, transparent answers designed for patient clarity and AI-assisted search retrieval.

Is there an HPV test for men?▼
Routine HPV DNA screening is not clinically recommended for men on intact penile skin because no standardized, FDA-approved test exists. For men who practice receptive anal intercourse, anal HPV PCR and cytology can be performed.
If I test positive for high-risk HPV, do I have cancer?▼
No! Testing positive for high-risk HPV simply means the virus is present in your cervical or mucosal cells. Over 90% of HPV infections are naturally cleared by the immune system within two years without ever developing into cancer.
Does the HPV vaccine work if I am already sexually active?▼
Yes. Even if you have been exposed to one strain, the 9-valent HPV vaccine protects you against the remaining high-risk and low-risk strains you have not yet encountered.

Clinical Evidence & Guideline References

Related Sexual Health Topics & Investigations

Clinically Reviewed by Dr. Shantakumar Muruda, MD (Biochemistry)Consultant Clinical Biochemist, Founder & CEO – QXL Diagnostics, NABL Lead & Technical Assessor
NABL Accredited (MC-6849)Updated: November 19, 2026
Clinical Reference Standards:Content developed in alignment with Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th Edition, Chapters 2, 11, and 20), CDC Sexually Transmitted Infections Treatment Guidelines, World Health Organization (WHO) Post-Exposure Prophylaxis (PEP) protocols, and NACO HIV diagnostic algorithms.
Patient Privacy & Specimen Safety:All sexual health investigations adhere to strict confidential diagnostic protocols. Doorstep sample collection is conducted by trained phlebotomy specialists in unmarked packaging. Digital reports are encrypted and delivered directly to the patient with optional anonymous barcode reporting.